Results 271 to 280 of about 250,918 (350)
Recent Progress and Potential of G4 Ligands in Cancer Immunotherapy. [PDF]
Lin J+7 more
europepmc +1 more source
Cancer cell membrane‐based nanoparticles (CCM‐NPs) and cancer cell‐derived small extracellular vesicles (CsEVs) are emerging as promising drug delivery systems for targeted cancer treatment. Advances in nanotechnology have paved the way for innovative drug delivery systems that enhance the effectiveness of cancer treatment.
Wei Zhang+4 more
wiley +1 more source
Wild-type p53 can inhibit oncogene-mediated focus formation.
Daniel Eliyahu+4 more
openalex +1 more source
Protein structural context of cancer mutations reveals molecular mechanisms and candidate driver genes. [PDF]
Chillón-Pino D+3 more
europepmc +1 more source
Integrated bioinformatics analysis to explore potential therapeutic targets and drugs for small cell carcinoma of the esophagus. [PDF]
Zhu M+5 more
europepmc +1 more source
A Single‐Molecule Liposome Assay for Membrane Permeabilisation
Cell membrane disruption is associated with numerous diseases and underlies the activity of various antimicrobial agents. The rapid screening of compounds capable of disrupting or permeabilising biological membranes is essential to the search for new therapeutic drugs.
Krzysztof Marek Bąk+9 more
wiley +1 more source
Transcriptome-scale analysis of functional alternative back-splicing events in colorectal cancer. [PDF]
Ning Q+10 more
europepmc +1 more source